2-amino-9-[(1R,6R,8R,9S,10R,15R,17R,18S)-9,18-difluoro-3,12-dihydroxy-8-(4-oxo-5H-pyrrolo[2,3-b]pyridin-1-yl)-3,12-bis(sulfanylidene)-2,4,7,11,13-pentaoxa-16-thia-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one
C22H23F2N7O9P2S3 — CID 157051053
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-amino-9-[(1R,6R,8R,9S,10R,15R,17R,18S)-9,18-difluoro-3,12-dihydroxy-8-(4-oxo-5H-pyrrolo[2,3-b]pyridin-1-yl)-3,12-bis(sulfanylidene)-2,4,7,11,13-pentaoxa-16-thia-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one
2-amino-9-[(1R,6R,8R,9S,10R,15R,17R,18S)-9,18-difluoro-3,12-dihydroxy-8-(4-oxo-5H-pyrrolo[2,3-b]pyridin-1-yl)-3,12-bis(sulfanylidene)-2,4,7,11,13-pentaoxa-16-thia-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one (PubChem CID 157051053) has the molecular formula C22H23F2N7O9P2S3 and a molecular weight of 725.61 g/mol. Its IUPAC name is 2-amino-9-[(1R,6R,8R,9S,10R,15R,17R,18S)-9,18-difluoro-3,12-dihydroxy-8-(4-oxo-5H-pyrrolo[2,3-b]pyridin-1-yl)-3,12-bis(sulfanylidene)-2,4,7,11,13-pentaoxa-16-thia-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one.
Molecular Properties
| Compound Name | 2-amino-9-[(1R,6R,8R,9S,10R,15R,17R,18S)-9,18-difluoro-3,12-dihydroxy-8-(4-oxo-5H-pyrrolo[2,3-b]pyridin-1-yl)-3,12-bis(sulfanylidene)-2,4,7,11,13-pentaoxa-16-thia-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one |
|---|---|
| PubChem CID | 157051053 |
| Molecular Formula | C22H23F2N7O9P2S3 |
| Molecular Weight | 725.61 g/mol |
| Exact Mass | 725.02 |
| IUPAC Name | 2-amino-9-[(1R,6R,8R,9S,10R,15R,17R,18S)-9,18-difluoro-3,12-dihydroxy-8-(4-oxo-5H-pyrrolo[2,3-b]pyridin-1-yl)-3,12-bis(sulfanylidene)-2,4,7,11,13-pentaoxa-16-thia-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one |
| SMILES | Nc1nc2c(ncn2[C@@H]2S[C@@H]3COP(O)(=S)O[C@H]4[C@H](F)[C@H](n5ccc6c5N=CCC6=O)O[C@@H]4COP(O)(=S)O[C@@H]2[C@@H]3F)c(=O)[nH]1 |
| InChI | InChI=1S/C22H23F2N7O9P2S3/c23-12-11-6-37-42(35,44)39-15-10(38-20(13(15)24)30-4-2-8-9(32)1-3-26-17(8)30)5-36-41(34,43)40-16(12)21(45-11)31-7-27-14-18(31)28-22(25)29-19(14)33/h2-4,7,10-13,15-16,20-21H,1,5-6H2,(H,34,43)(H,35,44)(H3,25,28,29,33)/t10-,11-,12-,13+,15-,16-,20-,21-,41?,42?/m1/s1 |
| InChIKey | GKSZBUCNNMVFHV-XXYBLNITSA-N |
| XLogP | 1.93 |
| TPSA | 210.56 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 725.61 |
| LogP ≤ 5 | 1.93 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157051053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.